NASD · Healthcare · Medical Care Facilities · Thailand
NewGenIvf Group Ltd is a micro cap company (market value under $300 million) in the Medical Care Facilities industry.
Intrinsic value, DCF valuation, financial health and value investing analysis for the NewGenIvf Group Ltd stock.
Undervalued: intrinsic value $0.57 per share, market price $0.17, margin of safety 70.1% (as of 2026-11-17).
Its through-the-cycle earnings (0.8% median margin), capitalised at 6.0% with no growth, values the shares at $0.57; the price of $0.17 is 70% below that value.
All 48 Medical Care Facilities stocks
NIVF is undervalued (as of the 2026-11-17 close). Its through-the-cycle earnings (0.8% median margin), capitalised at 6.0% with no growth, values the shares at $0.57; the price of $0.17 is 70% below that value.
$0.57 per share (as of the 2026-11-17 close), against a market price of $0.17. That is a margin of safety of 70.1%. The value comes from the one valuation method that applies to this company, recomputed every night after the US close.